Non-Pharmacologic In-Patient Management of Pneumonia
Non-pharmacologic management strategies are essential components of comprehensive pneumonia care and should be implemented alongside appropriate antibiotic therapy to optimize patient outcomes and reduce mortality. 1
Respiratory Support
- Oxygen therapy should be provided to maintain oxygen saturation ≥92%, as saturations below this threshold are associated with increased morbidity and mortality 2
- Non-invasive ventilation (NIV) should be considered for patients with hypoxemia or respiratory distress unless they require immediate intubation due to severe hypoxemia (PaO₂/FiO₂ ratio <150) and bilateral alveolar infiltrates 1, 3
- Low-tidal-volume ventilation (6 cm³/kg of ideal body weight) should be used for patients requiring mechanical ventilation who have diffuse bilateral pneumonia or acute respiratory distress syndrome 1
Early Mobilization and Fluid Management
- Early mobilization should be implemented for all patients to prevent complications of bed rest and accelerate recovery 1
- Low molecular weight heparin should be administered to patients with acute respiratory failure to prevent thromboembolic complications 1
- Adequate fluid resuscitation is essential for hypotensive patients with severe pneumonia 1
Monitoring and Assessment
- Regular assessment of clinical stability including temperature, respiratory rate, blood pressure, oxygen saturation, and mental status should be performed 1
- Screening for occult adrenal insufficiency should be considered in hypotensive, fluid-resuscitated patients with severe CAP 1
- Structured reassessment of non-responding patients (those without clinical improvement after 48-72 hours of appropriate therapy) is necessary to identify potential complications or alternative diagnoses 4
Transition of Care
Switch from intravenous to oral therapy when patients are:
- Hemodynamically stable and improving clinically
- Able to ingest medications
- Have a normally functioning gastrointestinal tract 1
Discharge planning should begin when patients are clinically stable, with no other active medical problems, and have a safe environment for continued care 1
- Inpatient observation while receiving oral therapy is not necessary once clinical stability is achieved 1
Infection Control Measures
- Droplet precautions and careful routine infection control measures should be implemented for patients with suspected influenza or other respiratory pathogens 1
- Isolation precautions appropriate to the suspected pathogen should be maintained until the infectious risk is resolved 1
Follow-up Care
- Clinical review should be arranged for all patients at around 6 weeks, either with their general practitioner or in a hospital clinic 1
- Follow-up chest radiograph should be obtained approximately 4-6 weeks after hospital discharge to establish a new radiographic baseline and exclude underlying malignancy, particularly in older smokers 1
- Patients should be offered access to information about pneumonia such as a patient information leaflet at discharge or follow-up 1
Special Considerations
For aspiration pneumonia, additional non-pharmacologic measures may include:
- Elevation of the head of the bed
- Careful attention to feeding strategies
- Speech therapy consultation for swallowing assessment 1
For non-responding pneumonia, consider:
By implementing these evidence-based non-pharmacologic strategies alongside appropriate antimicrobial therapy, clinicians can optimize outcomes for patients hospitalized with pneumonia and reduce the risk of complications and mortality.